3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects

Sponsor
Southwest Hospital, China (Other)
Overall Status
Unknown status
CT.gov ID
NCT03185286
Collaborator
(none)
40
1
1
48
0.8

Study Details

Study Description

Brief Summary

This study aims to use 3D-printed personalized metal implants for bone defect surgeries in order to reduce pain of the patients.

Condition or Disease Intervention/Treatment Phase
  • Device: 3d-printed personalized metal implant
N/A

Detailed Description

Bone defects are common in ankle disease, and the conventional treatment includes autologous or allogeneic bone grafts. However, autologous bone graft may cause complications and its source is rather limited; allogeneic bone graft may cause disease transmission and the mechanical strength of the graft is low after processing.

The 3D printing technology has provided a new way of solving this problem. It has the following technical advantages: wide range of graft sources, high mechanical strength, and can be prepared in advance according to various shapes.

Preparation procedure: first, establish the individualized ankle model according to the patient's ankle CT scan data and then prepare the implant model; second, conduct surgery rehearsal and place the implant model in the ankle model for observation; third, after confirmation, use titanium alloy in the 3D printing machine to prepare the individualized metal implant, which is in line with the Chinese National Standard "Wrought titanium and titanium alloy for surgical implants" (GB/T 13810-2007); fourth, implant the individualized metal implant into the bone defect area after sterilization.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects
Actual Study Start Date :
Dec 31, 2015
Anticipated Primary Completion Date :
Dec 31, 2018
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: 3D-printed personalized metal implant

3D-printed personalized metal implant will be used in bone defect surgeries.

Device: 3d-printed personalized metal implant
3d-printed personalized metal implant will be used in subtalar arthrodesis.

Outcome Measures

Primary Outcome Measures

  1. Visual Analogue Scale (VAS) [Postoperative 24 months]

    The decrease in VAS score from baseline

Secondary Outcome Measures

  1. American Orthopedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale [Postoperative 24 months]

    The increase in AOFAS score from baseline

  2. Lower limb alignment [Postoperative 24 months]

    Analyze the lower limb alignment by radiography

  3. Osteotylus growth [Postoperative 24 months]

    Analyze the osteotylus growth by radiography

  4. Implant displacement [Postoperative 24 months]

    Assess the implant displacement by radiography

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Receive ankle or subtalar arthrodesis;

  • Refuse to use autologous bone graft or allogeneic bone graft.

Exclusion Criteria:
  • The local defect area is small;

  • Refuse to use permanent metal metal implant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Southwest Hospital Chongqing Chongqing China 400030

Sponsors and Collaborators

  • Southwest Hospital, China

Investigators

  • Principal Investigator: Xiaojun Duan, MD, Southwest Hospital, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xiaojun Duan, Deputy Director of the Center for Joint Surgery, Southwest Hospital, China
ClinicalTrials.gov Identifier:
NCT03185286
Other Study ID Numbers:
  • 3DIMPLANT
First Posted:
Jun 14, 2017
Last Update Posted:
Jun 14, 2017
Last Verified:
Jun 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xiaojun Duan, Deputy Director of the Center for Joint Surgery, Southwest Hospital, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2017